M1A.23
Drug-induced chronic gout, wrist
Clinical Classification Guidelines
Medical Intelligence & Overview
Drug-induced chronic gout in the wrist, classified under ICD-10 code M1A.23, is a form of gout caused by the long-term use of certain medications. Gout is a type of inflammatory arthritis characterized by the accumulation of uric acid crystals in joints, leading to pain and inflammation. When drugs are a contributing factor, they can elevate uric acid levels in the body, resulting in chronic gout that specifically affects the wrist joints. Recognizing this condition is important for targeted management and to prevent joint damage.
Causes & Symptoms
Clinical Causes: Prolonged use of certain medications that increase uric acid levels, such as diuretics (e.g., thiazide and loop diuretics) Medications used for immunosuppression, like cyclosporine Low-dose aspirin therapy, which can elevate uric acid levels in some cases Other drugs that impair uric acid excretion or increase production Existing health conditions that predispose to high uric acid levels, which may be exacerbated by medication use
Key Symptoms: Persistent pain and swelling in the wrist joints Chronic joint stiffness and reduced mobility in the affected wrist Presence of tophi (urate crystal deposits) around the wrist area in advanced cases Redness and warmth over the joint during flare-ups Recurrent episodes of gout attacks that worsen over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation, medical history, and laboratory tests. Key steps include: - Reviewing medication history to identify drugs associated with increased uric acid levels - Blood tests measuring serum uric acid levels, often elevated in gout - Imaging studies like ultrasound or X-ray to detect joint damage or tophi - Arthrocentesis, where joint fluid is sampled to identify uric acid crystals under microscopic examination - Differential diagnosis to exclude other forms of arthritis or joint conditions These assessments help confirm the diagnosis of drug-induced chronic gout in the wrist and rule out other joint disorders.
Treatment Protocols: Managing drug-induced chronic gout involves multiple approaches aimed at controlling symptoms, reducing uric acid levels, and addressing medication use. Typical treatments include: - Discontinuing or adjusting the medication contributing to increased uric acid levels, under medical supervision - Use of anti-inflammatory medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) during flare-ups - Colchicine for acute attack management - Long-term urate-lowering therapy (e.g., allopurinol or febuxostat) to maintain serum uric acid within target ranges - Lifestyle modifications including dietary changes to reduce purine intake, maintaining a healthy weight, and staying well-hydrated - Regular monitoring of uric acid levels to prevent further joint damage In some cases, specific treatments may be tailored based on the patient's overall health, medication profile, and severity of gout.
Clinical Advice & FAQs
Billing Guidance
Is M1A.23 a billable ICD-10 code?
Yes, M1A.23 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.23?
Clinical documentation must specify the nature of Drug-induced chronic gout, wrist and any associated comorbidities for accurate reporting.
Cite this Clinical Reference